WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
Category: #headlines  By Pranali Mehta  Date: 2021-02-17
  • share
  • Twitter
  • Facebook
  • LinkedIn
WHO grants EUA to AstraZeneca’s COVID-19 vaccine, shares soar by 6%
  • AstraZeneca COVID-19 vaccine has received approval in over 50 countries.
  • AstraZeneca vaccine is the second to be issued by the UN health agency, with Pfizer-BioNTech being the first.

Shares of AstraZeneca plc soared by 6% after the World Health Organization (WHO) reportedly granted a EUA (emergency use authorization) to its COVID-19 vaccine. This move could enable partners of the UN agency to ship millions of doses to economies as part of its global initiative to control the ongoing Coronavirus pandemic.

WHO stated that it would clear the British-Swedish multinational pharmaceutical company vaccines which are being developed by South Korea’s AstraZeneca-SKBio and the Serum Institute of India.

WHO’s declaration is expected to prompt the distribution of hundreds of millions of doses to economies that have joined the UN-backed COVAX initiative aimed at providing vaccines to the most vulnerable people in the world.

It is worth noting that the AstraZeneca vaccine has already been approved in over 50 countries, including Mexico, Argentina, India, and Britain. It is an inexpensive and simple dose to manage as compared to the Pfizer-BioNTech vaccine, which requires deep-cold storage, which is not common in many developing nations, sources claimed.

The use of the AstraZeneca COVID-19 vaccine was recommended by WHO experts, especially for people over the age of 18 years as well as in countries that have found COVID-19 variants.

Sources confirmed that post this development, the shares of the India unit of AstraZeneca Pharma increased by 9.7% to reach a high of USD 54.70 (Rs 3,985) on BSE (Bombay Stock Exchange).

After the Pfizer-BioNTech vaccine was approved in December by the WHO, the AstraZeneca vaccine is just the second approval given by the UN Health Agency.

Meanwhile, Australia has recently approved AstraZeneca’s COVID-19 vaccine and has requested around 53.8 million doses.

Source Credit –

https://economictimes.indiatimes.com/markets/stocks/news/astrazeneca-pharma-surges-10-as-who-okays-covid-vaccine-for-emergency-use/articleshow/80963175.cms

 

 

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

Facebook’s cloud gaming services launched for iPhone and iPad users
Facebook’s cloud gaming services launched for iPhone and iPad users
By Pranali Mehta

Users from Mexico, Canada, and the United States can now stream Facebook Games on Apple devices. Facebook Games has more than 1.5 million active users per month and is currently offering 25 cloud-streamed games. American social media giant Face...

Clubhouse ends invite-only access; now open for all iOS, Android users
Clubhouse ends invite-only access; now open for all iOS, Android users
By Pranali Mehta

The audio chat forum Clubhouse recently ended its invitation-only mode and opened its virtual rooms for all users. The waitlist system has been removed and anyone using iOS or Android smartphones can join the chat now. The founders Rohan Seth and Pa...

GHG emissions could exceed record high levels by 2023, predicts IEA
GHG emissions could exceed record high levels by 2023, predicts IEA
By Pranali Mehta

The International Energy Agency has warned that global greenhouse gas emissions (GHG) could reach new highs in the coming years as governments have failed to "build back better" from the Covid19 outbreak. According to the agency, emissions...